A biotechnology firm that leverages advanced gene-editing platforms to create innovative treatments for genetic disorders and oncology.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
EdiGene is a clinical-stage biotechnology company specializing in gene-editing technologies to develop transformative therapies for genetic diseases and cancer. Its proprietary platforms, LEAPER™ for RNA editing and MAGIC for immune cell therapy, drive its diverse therapeutic pipeline.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
EdiGene Management Team
EdiGene Valuations & Financials
View real-time NPM data on EdiGene stock including daily EdiGene stock price estimates, valuation history, and historical share price information. Access EdiGene financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track EdiGene pricing across six independent market signals. Looking for private company due diligence data sources on EdiGene? Get in touch to learn more.
Similar Companies
like EdiGene
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Cargomatic
Commerce & Marketplaces
Operates an on-demand network connecting local shippers with small trucking companies.
KETOS
Industrials
Tracks water quality in real time and delivers predictive insights across many parameters.
Ladder
FinTech
Offers instant, simple, and smart direct-to-consumer, term life insurance online without fees or commissioned sales agents."
Curai
Healthcare & Life Sciences
Provide virtual primary care that augments clinicians with AI-assisted workflows and chat-based medical support.
Tarana Wireless
Enterprise Software
Suburban gigabit broadband system designed to deliver gigabit speeds over non-line-of-sight connections.
Kashable LLC
FinTech
Provides employer-sponsored loans that enable employees to access credit and repay through payroll deductions.
Vectra
Cybersecurity
Provides AI-powered cybersecurity solutions for detecting and responding to network threats across hybrid environments.
NanoCellect Biomedical
Healthcare & Life Sciences
Develops cell analysis systems that enable precise isolation and characterization of individual cells for research workflows.
FAQ
We have answers
EdiGene stock does not trade on public stock exchanges. EdiGene stock is considered a private security and you need to be an accredited investor to trade shares. To invest in EdiGene stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
EdiGene Stock does not trade on public stock exchanges. In order to sell EdiGene shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
EdiGene does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view EdiGene share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for EdiGene stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell EdiGene stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in EdiGene stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
EdiGene is a private company and has not had an IPO. There is currently no EdiGene IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to EdiGene IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
